tiprankstipranks
Trending News
More News >
Basilea Pharmaceutica (CH:BSLN)
:BSLN
Switzerland Market

Basilea Pharmaceutica (BSLN) Ratios

Compare
2 Followers

Basilea Pharmaceutica Ratios

CH:BSLN's free cash flow for Q4 2024 was CHF0.52. For the 2024 fiscal year, CH:BSLN's free cash flow was decreased by CHF and operating cash flow was CHF0.39. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
2.34 3.20 2.34 1.38 4.46
Quick Ratio
2.02 2.64 2.02 1.25 4.03
Cash Ratio
0.49 1.26 0.49 0.32 1.11
Solvency Ratio
0.06 0.07 0.06 -0.01 -0.04
Operating Cash Flow Ratio
0.09 0.30 0.09 -0.18 -1.08
Short-Term Operating Cash Flow Coverage
0.19 0.92 0.19 -0.26 21.18
Net Current Asset Value
CHF -66.20MCHF -31.15MCHF -66.20MCHF -64.81MCHF -108.31M
Leverage Ratios
Debt-to-Assets Ratio
0.85 0.74 0.85 0.89 1.05
Debt-to-Equity Ratio
-9.03 -12.86 -9.03 -3.74 -2.37
Debt-to-Capital Ratio
1.12 1.08 1.12 1.37 1.73
Long-Term Debt-to-Capital Ratio
1.19 1.12 1.19 2.63 1.74
Financial Leverage Ratio
-10.66 -17.32 -10.66 -4.22 -2.25
Debt Service Coverage Ratio
0.54 0.87 0.54 0.05 -0.30
Interest Coverage Ratio
1.48 1.71 1.48 0.11 -2.29
Debt to Market Cap
0.31 0.26 0.31 0.46 0.43
Interest Debt Per Share
16.71 11.66 16.71 19.69 24.55
Net Debt to EBITDA
5.74 2.96 5.74 24.39 -83.39
Profitability Margins
Gross Profit Margin
81.86%83.00%81.86%83.75%81.15%
EBIT Margin
15.64%13.74%15.64%2.88%-5.55%
EBITDA Margin
17.74%14.71%17.74%4.54%-1.75%
Operating Profit Margin
11.06%12.18%11.06%0.79%-18.22%
Pretax Profit Margin
8.19%6.64%8.19%-4.59%-11.49%
Net Profit Margin
8.22%6.63%8.22%-4.61%-11.53%
Continuous Operations Profit Margin
8.22%6.63%8.22%-4.61%-11.53%
Net Income Per EBT
100.37%99.90%100.37%100.54%100.37%
EBT Per EBIT
74.05%54.47%74.05%-579.69%63.06%
Return on Assets (ROA)
5.50%6.03%5.50%-2.76%-6.41%
Return on Equity (ROE)
-58.64%-104.48%-58.64%11.66%14.43%
Return on Capital Employed (ROCE)
11.19%15.28%11.19%1.61%-12.95%
Return on Invested Capital (ROIC)
8.85%13.40%8.85%0.60%-13.05%
Return on Tangible Assets
5.51%6.05%5.51%-2.77%-6.43%
Earnings Yield
2.24%2.47%2.24%-1.43%-2.69%
Efficiency Ratios
Receivables Turnover
2.39 5.65 2.39 2.30 3.94
Payables Turnover
140.33 4.58 140.33 2.27 1.83
Inventory Turnover
1.11 1.01 1.11 1.06 1.14
Fixed Asset Turnover
6.85 7.67 6.85 50.67 24.20
Asset Turnover
0.67 0.91 0.67 0.60 0.56
Working Capital Turnover Ratio
1.77 1.54 1.77 1.23 0.90
Cash Conversion Cycle
479.97 344.70 479.97 343.28 214.66
Days of Sales Outstanding
152.42 64.58 152.42 158.81 92.64
Days of Inventory Outstanding
330.15 359.77 330.15 345.46 321.57
Days of Payables Outstanding
2.60 79.65 2.60 160.98 199.56
Operating Cycle
482.57 424.35 482.57 504.26 414.21
Cash Flow Ratios
Operating Cash Flow Per Share
0.59 1.19 0.59 -2.74 -5.27
Free Cash Flow Per Share
0.32 1.10 0.32 -2.81 -5.49
CapEx Per Share
0.28 0.09 0.28 0.07 0.22
Free Cash Flow to Operating Cash Flow
0.53 0.93 0.53 1.03 1.04
Dividend Paid and CapEx Coverage Ratio
2.14 13.78 2.14 -37.23 -23.90
Capital Expenditure Coverage Ratio
2.14 13.78 2.14 -37.23 -23.90
Operating Cash Flow Coverage Ratio
0.04 0.11 0.04 -0.15 -0.22
Operating Cash Flow to Sales Ratio
0.05 0.09 0.05 -0.22 -0.42
Free Cash Flow Yield
0.69%3.12%0.69%-6.88%-10.32%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
44.72 40.50 44.72 -69.98 -37.12
Price-to-Sales (P/S) Ratio
3.68 2.69 3.68 3.23 4.28
Price-to-Book (P/B) Ratio
-26.22 -42.32 -26.22 -8.16 -5.36
Price-to-Free Cash Flow (P/FCF) Ratio
144.75 32.04 144.75 -14.54 -9.69
Price-to-Operating Cash Flow Ratio
76.99 29.72 76.99 -14.93 -10.09
Price-to-Earnings Growth (PEG) Ratio
-0.16 -2.75 -0.16 1.18 1.19
Price-to-Fair Value
-26.22 -42.32 -26.22 -8.16 -5.36
Enterprise Value Multiple
26.47 21.22 26.47 95.50 -327.45
Enterprise Value
693.80M 492.00M 693.80M 642.03M 733.17M
EV to EBITDA
26.47 21.22 26.47 95.50 -327.45
EV to Sales
4.70 3.12 4.70 4.33 5.74
EV to Free Cash Flow
184.87 37.24 184.87 -19.53 -13.00
EV to Operating Cash Flow
98.33 34.54 98.33 -20.05 -13.54
Tangible Book Value Per Share
-1.80 -0.88 -1.80 -5.07 -9.99
Shareholders’ Equity Per Share
-1.75 -0.83 -1.75 -5.02 -9.93
Tax and Other Ratios
Effective Tax Rate
>-0.01 <0.01 >-0.01 >-0.01 >-0.01
Revenue Per Share
12.46 13.15 12.46 12.68 12.41
Net Income Per Share
1.02 0.87 1.02 -0.58 -1.43
Tax Burden
1.00 1.00 1.00 1.01 1.00
Interest Burden
0.52 0.48 0.52 -1.59 2.07
Research & Development to Revenue
0.50 0.49 0.50 0.63 0.76
SG&A to Revenue
0.21 0.21 0.21 0.20 0.23
Stock-Based Compensation to Revenue
0.02 0.03 0.02 0.03 0.03
Income Quality
0.58 1.36 0.58 4.69 3.68
Currency in CHF
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis